Rong Wang
- Biochemistry top 0.2%
- Molecular Biology top 0.5%
- RNA modifications and cancer 17
- Ubiquitin and proteasome pathways 14
- Cancer Research top 1%
- Cancer-related molecular mechanisms research 27
- MicroRNA in disease regulation 20
- Infectious Diseases top 0.5%
- Viral gastroenteritis research and epidemiology 15
- Microbiology top 0.5%
-
- Animal Virus Infections Studies 21
-
- Virus-based gene therapy research 19
-
- Adipose Tissue and Metabolism 14
- Co-authors
- Georgia DoliosEdward M. MarcottePeng LüMichaël OttoChristine VogelDawn BrasaemleLawrence ShapiroXin Yao
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Rong Wang
463 papers receiving 13.7k citations
Hit Papers
Peers
Comparison fields: 5 of 179
- Biochemistry 890
- Molecular Biology 7.8k
- Cancer Research 1.6k
- Infectious Diseases 1.9k
- Microbiology 571
Countries citing papers authored by Rong Wang
This map shows the geographic impact of Rong Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rong Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rong Wang more than expected).
Fields of papers citing papers by Rong Wang
This network shows the impact of papers produced by Rong Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rong Wang. The network helps show where Rong Wang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Rong Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 2 | |
| 6 | 2023 | 8 | |
| 7 | 2023 | 10 | |
| 8 | 2023 | 12 | |
| 9 | 2023 | 3 | |
| 10 | 2023 | 16 | |
| 11 | 2023 | 5 | |
| 12 | 2023 | 5 | |
| 13 | 2023 | 22 | |
| 14 | 2022 | 3 | |
| 15 | 2018 | 81 | |
| 16 | 2015 | 27 | |
| 17 | 2015 | 30 | |
| 18 | 2008 | 44 | |
| 19 | 2007 | 164 | |
| 20 | 2003 | 17 |
About Rong Wang
Rong Wang is a scholar working on Cancer Research, Aging, Molecular Biology, Immunology and Animal Science and Zoology, having authored 498 papers that have together received 13.9k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (27 papers), Animal Virus Infections Studies (21 papers), MicroRNA in disease regulation (20 papers), Virus-based gene therapy research (19 papers), RNA modifications and cancer (17 papers), Viral gastroenteritis research and epidemiology (15 papers), Ubiquitin and proteasome pathways (14 papers) and Adipose Tissue and Metabolism (14 papers). The work is most often cited by research in Biochemistry (890 citations), Molecular Biology (7.8k citations), Cancer Research (1.6k citations), Infectious Diseases (1.9k citations) and Microbiology (571 citations). Rong Wang has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Georgia Dolios, Edward M. Marcotte, Peng Lü, Michaël Otto, Christine Vogel, Dawn Brasaemle, Lawrence Shapiro, Xin Yao, Shu Y. Queck and Yan‐Jin Zhang. Their work appears in journals such as PLoS ONE, Scientific Reports, Frontiers in Immunology, BMC Genomics and Journal of Virology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.